A detailed history of Umpqua Bank transactions in Geron Corp stock. As of the latest transaction made, Umpqua Bank holds 10,000 shares of GERN stock, worth $33,500. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$33,500
Previous $42.4 Million 7.08%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.75 - $3.44 $17,500 - $34,400
10,000 New
10,000 $33 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.27B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Umpqua Bank Portfolio

Follow Umpqua Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umpqua Bank, based on Form 13F filings with the SEC.

News

Stay updated on Umpqua Bank with notifications on news.